Ctsd Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox Gene
| gene_name = CTSD
| full_name = cathepsin D
| chromosome = 11
| location = 11p15.5
| ncbi_gene_id = 1509
| omim = 116840
| ensembl = ENSG00000141428
| uniprot = P07339
| aliases = CLN10, CPSD
}}
CATHEAPSIN D is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of CATHEAPSIN D is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The CTSD gene encodes cathepsin D, an aspartyl protease belonging to the peptidase family A1. Cathepsin D is primarily localized to lysosomes where it functions as an endopeptidase, degrading proteins in the acidic lysosomal environment. It is synthesized as a preproenzyme (52 kDa) that undergoes processing to become a mature, active enzyme (31 kDa). Cathepsin D is expressed in most cell types and is particularly abundant in cells with high secretory or degradative activity.
Cathepsin D plays a complex role in Alzheimer's disease:
In Parkinson's disease:
CTSD mutations cause:
Cathepsin D activity is dysregulated in ALS:
Cathepsin D is expressed in:
Expression is upregulated under conditions of cellular stress.
The study of Ctsd Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.